Medical device treatment for acute ischemic stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a medical device for treating acute ischemic stroke (a stroke caused by a blocked blood vessel in the brain). The device is used along with standard care to try to improve recovery and reduce disability.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You should have a severe stroke, meaning you have noticeable weakness or trouble speaking (a score of 6 or higher on a stroke severity scale).
- Before this stroke, you were able to do your daily activities without help (a score of 0 or 1 on a disability scale).
- A scan must show a blockage in a large blood vessel in the front part of your brain.
- The scan should also show that the brain tissue is still mostly healthy, with a score above 6 on a special scale.
- You must be able to provide informed consent, and you cannot have certain other severe medical conditions or a contrast dye allergy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device that removes blood clots in the brain using suction. It is for people having a large-vessel ischemic stroke who can be treated within 8 hours of symptoms starting.
This study tests a new device called Ceretrieve that is designed to remove blood clots from large arteries in the brain for people having a severe ischemic stroke. If you are eligible, you will receive the device treatment (a mechanical thrombectomy) within 24 hours of your first symptoms.
This study tests a rescue treatment for people having a major stroke caused by a blocked artery in the brain that also has severe narrowing. If doctors can't fully open the artery with standard clot removal, this study looks at whether additional treatments can help.
This trial tests a new catheter device to remove blood clots in the brain for people having a severe stroke. The goal is to restore blood flow and improve recovery.
This trial tests a new catheter device to remove blood clots from smaller brain arteries in people having a stroke. It aims to see if the device is safe and effective for patients treated within 24 hours of symptoms starting.
This trial tests whether giving a clot-dissolving medication directly into the brain's blood vessels during a standard procedure (mechanical thrombectomy) can improve outcomes for people with a stroke caused by a blockage in a medium-sized artery. It may be an option for patients who arrive at the hospital within 24 hours of symptom onset and have enough salvageable brain tissue.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.